Mesotherapy Market Forecast to 2030 - Share, Growth, Size
美塑疗法市场预测可以帮助该市场的利益相关者制定增长战略。预计该市场将从 2022 年的 5.612 亿美元增长到 2030 年的 11.486 亿美元;预计 2022-2030 年的复合年增长率为 9.4%。
市场洞察和分析师观点:
简化和微创手术、应用范围广泛以及技术进步带来的舒适度、效率和效果的改善等因素推动了 美塑疗法市场的增长。然而,潜在的副作用和监管挑战阻碍了市场的增长。此外,联合疗法的日益普及预计将在未来几年带来新的美塑疗法市场趋势。
增长动力:
简化和微创手术以及广泛的应用推动市场增长
微创美容手术比侵入性手术具有多种优势,包括停机时间最短、恢复速度更快、并发症和副作用风险降低,以及适用于更广泛的患者。美塑疗法是一种流行的微创美容手术,只需使用简单的注射剂组合即可获得出色的效果。微创手术和简化流程是美塑疗法在美容和医疗应用中的主要优势。这种疗法广泛用于头发和皮肤再生治疗,而其医疗应用主要包括疼痛管理。美塑疗法允许在身体各个部位进行局部治疗,剂量要求最小,副作用较少。美塑疗法中使用的维生素、矿物质和酶等产品对皮肤有益,使其成为昂贵手术的更好替代品。除了解决各种皮肤问题外,美塑疗法还有助于保持皮肤水润并提亮肤色。
美塑疗法可以根据每位患者的需求和目标进行定制。通过结合不同的成分并调整注射技术,医疗保健提供者可以根据特定问题(如痤疮疤痕、细纹、皱纹和头发稀疏)定制治疗方案。这种个性化方法与寻求提供自然效果的定制解决方案的患者产生共鸣。美塑疗法也被广泛用作抽脂术的替代方案,抽脂术是一种侵入性且成本高昂的手术。因此,简化和微创的手术以及广泛的应用推动了美塑疗法市场的增长。
限制:
潜在的副作用和监管挑战
目前,美国食品药品管理局 (FDA) 已批准有限数量的中胚层疗法药物。根据美国整形外科医师协会 (ASPS) 的说法,一旦 FDA 批准了某种药物,执业医师可能会开出该药物用于其指定用途以外的其他用途。在中胚层疗法中,多种药物或物质被组合以产生新的配方,这不是 FDA 批准的做法。因此,由于监管挑战,中胚层疗法产品仅在有限情况下使用。因此,由于缺乏监管和标准化,新加坡和巴西已禁止某些中胚层疗法程序。此外,这些程序可能会产生各种副作用,包括恶心、肿胀、敏感、瘀伤、黑斑(皮肤上)、感染、疤痕、瘙痒和疼痛。由于中胚层疗法产品直接应用于目标区域,因此副作用不确定。因此,潜在的副作用和监管挑战(导致一些国家禁止使用)以及有限数量的获批产品阻碍了中胚层疗法市场的增长。mesotherapy. According to the American Society of Plastic Surgeons (ASPS), once the FDA approves a drug, a licensed physician may prescribe a drug for use other than its indicated purpose. In the case of mesotherapy, multiple drugs or substances are combined to create a new formulation, which is not an FDA-approved practice. Hence, mesotherapy products are used in limited cases due to regulatory challenges. Consequently, some mesotherapy procedures have been banned in Singapore and Brazil due to a lack of regulation and standardization. Moreover, these procedures may be followed by various side effects, including nausea, swelling, sensitivity, bruising, dark patches (on the skin), infection, scars, itching, and pain. The side effects are uncertain as mesotherapy products are applied directly to the target area. Thus, potential side effects and regulatory challenges (resulting in bans in a few countries), and the availability of a limited number of approved products hamper the growth of the mesotherapy market.
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
美塑疗法市场:
复合年增长率(2022 - 2030 年)9.4%- 2022 年市场规模
5.612 亿美元 - 2030 年市场规模
11.486 亿美元
市场动态
- 手术方式简化、微创,应用范围广泛
- 随着技术进步,舒适度、效率和成果得到改善
- 联合疗法的采用日益广泛
- 美容医疗旅游激增
关键人物;主力;重要一员
- 科鲁制药有限公司
- BCN 美学研究所
- 中胚层皮肤线
- 高露洁棕榄公司
- Skin Tech Pharma 集团
- HB 美学集团 SA
- 托斯卡尼 SL
- 科尔曼博士实验室有限公司
- 维塔卡公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 美塑疗法解决方案套件
- 中胚层治疗仪
- 美塑疗法填充剂套装
- 中胚层疗法化学换肤
- 抗衰老面膜
- 抗衰老和除皱治疗
- 面部年轻化
- 减脂
- 脱发
- 妊娠纹
- 痤疮和疤痕治疗
- 皮肤科诊所
- 美容诊所
- 医院
- 其他的
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
趋势:
联合疗法的采用日益广泛
个性化治疗、综合效果和微创选择的需求导致人们更倾向于联合疗法。这些疗法涉及使用多种治疗方式或产品,以实现比单一疗法更好的效果。根据 DermaNetwork.org 的说法,中胚层疗法可以与抽脂术、肉毒杆菌毒素、Purtox、微晶磨皮和 Fraxel 疗法相结合。例如,中胚层肉毒杆菌疗法(中胚层疗法和肉毒杆菌毒素的组合)广泛用于面部年轻化,通过将高稀释度的中胚层疗法溶液和肉毒杆菌毒素 注射到皮肤中。同样,将中胚层疗法和富血小板血浆 (PRP) 疗法相结合有助于刺激胶原蛋白和弹性蛋白的产生,这对修复皮肤很重要。PRP 利用自然愈合过程,提供比传统中胚层疗法程序更持久的效果(长达 6 个月)。正在进行各种研究,以了解中胚层疗法和 PRP 组合方法在治疗不同疾病方面的好处。目前,PRP 和中胚层疗法的组合用于治疗脱发。例如,在印度,先进的 Nano Meso 解决方案(美塑疗法和 PRP 的结合)可用于治疗脱发和头发稀疏,随后刺激男性和女性的头发生长。该解决方案有望对患有雄激素性脱发和年龄相关性脱发的人更有效。因此,组合疗法的趋势预计将有利于美塑疗法市场的表现,因为它可以带来诸如高品质的皮肤效果、更少的疼痛和更短的恢复时间等好处。
报告细分和范围:
中胚层疗法市场分析是通过考虑以下几个部分来进行的:产品类型、适应症和最终用户。
根据产品类型,市场细分为美塑疗法解决方案套装、美塑疗法设备、美塑疗法填充剂套装、美塑疗法化学换肤和抗衰老面膜。美塑疗法解决方案套装部分在 2022 年占据了最大的美塑疗法市场份额。美塑疗法填充剂套装部分预计在预测期内实现最高复合年增长率。美塑疗法解决方案套装包括乳霜、喷雾和注射液形式的左旋肉碱、丙酮酸、咖啡因和有机硅。由于美塑疗法解决方案的有效应用范围不断扩大,过去几年对美塑疗法解决方案的需求大幅增加。
根据适应症,市场分为抗衰老和皱纹治疗、面部年轻化、减脂、脱发、妊娠纹以及痤疮和疤痕治疗。抗衰老和皱纹治疗领域在 2022 年占据了最大的美塑疗法市场份额。预计在预测期内将实现最高的复合年增长率。用于治疗主要衰老状况(即皱纹、死皮细胞以及暗沉和松弛的皮肤)的美塑疗法的需求显着增加,尤其是由于该疗法的非侵入性和超细针头的使用。为了获得更好的治疗效果,抗衰老美塑疗法与激光年轻化、富血小板血浆 (PRP) 程序和透明质酸填充剂相结合。
按最终用户划分,市场分为皮肤科诊所、医院、美容诊所和其他。皮肤科诊所部分在 2022 年占据了美塑疗法市场的最大份额,预计在预测期内将实现最高的复合年增长率。有专门皮肤科治疗需求的患者往往会去皮肤科诊所寻求快速有效的服务。这些患者通常有特定的皮肤或头发状况,需要专家评估和管理。皮肤科医生接受过诊断和治疗各种皮肤问题的培训,例如痤疮、湿疹、牛皮癣、皮肤老化、色素沉着和脱发。皮肤科诊所提供的美塑疗法治疗是针对这些特定问题量身定制的,其定制配方旨在针对皮肤或头发问题的根本原因。皮肤科医生在诊断和治疗皮肤病方面的专业知识和专业知识是接受皮肤科诊所美塑疗法治疗的主要优势之一。
区域分析:
从地域上看,美塑疗法市场报告的范围包括北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据最大的市场份额。提供美塑疗法服务的诊所和医院数量不断增加,政府对美塑疗法在美容应用方面的支持不断增加,这些都促进了北美美塑疗法市场规模的扩大。在美国,由于对更有效、微创美容手术的需求持续增长,美塑疗法已成为一种极好的美容治疗选择。它在疼痛管理、运动医学和风湿病学等领域也越来越受到关注。随着美国老年人口的增加,对美塑疗法的需求可能会进一步增加,尤其是用于治疗疼痛和面部衰老迹象。根据美国皮肤病学会的数据,近 8000 万美国人患有雄激素性脱发(脱发),而痤疮每年影响多达 5000 万美国人。因此,美国人口中皮肤病的高发性有可能推动对美塑疗法产品和服务的需求。尽管美国食品和药物管理局 (FDA) 尚未批准任何美塑疗法,但它已批准了几种用于美塑疗法的成分。因此,它们被视为标签外批准成分。此外,美国整形外科医师协会 (ASPS) 不建议使用脂肪分解注射剂进行美塑疗法。因此,监管不确定性导致北美美塑疗法市场不规范。
美塑疗法市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 5.612亿美元 |
2030 年市场规模 | 11.486亿美元 |
全球复合年增长率(2022 - 2030 年) | 9.4% |
历史数据 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
行业发展和未来机遇:
根据公司新闻稿,中胚层疗法市场主要参与者的一些战略发展如下:
- 2023 年 7 月,PT Kalbe Farma Tbk(Kalbe)在印度尼西亚的美容治疗中引入了美塑疗法产品。Kalbe 进入美容治疗市场可以被视为利用生活方式趋势、更年轻的客户群以及某些地区医疗旅游兴起所带来的机会的努力。
- 2022年1月,高德美获得美国当局的反垄断批准,并完成对ALASTIN Skincare的收购,ALASTIN Skincare是一家致力于开发创新且经过临床测试的医师配发护肤产品的专业美容公司。
竞争格局和重点公司:
Koru Pharma Co Ltd、Institute BCN Esthetics SL、Mesoskinline ApS、Colgate Palmolive Co、Skin Tech Pharma Group SL、HB Aesthetics Group SA、Toskani SL、Dr. Korman Laboratories Ltd、Revitacare SAS、Ostar Beauty Sci-Tech Co Ltd、Mesoestetic E-Commerce SL、Galderma SA、Derm Beauty International Sdn Bhd 和 Mesotech Srl 是美塑疗法市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球日益增长的消费者需求。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market, by indication, is categorized into anti-aging and wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne and scar treatment. The anti-aging and wrinkle treatment segment held the largest mesotherapy market share in 2022 and it is anticipated to register the highest CAGR during the forecast period.
By product type, the market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy filler kits, mesotherapy chemical peels, and anti-aging masks. The mesotherapy solution kits segment held the largest mesotherapy market share in 2022 and mesotherapy filler kits segment is anticipated to register the highest CAGR during the forecast period.
The mesotherapy market is expected to be valued at US$ 1,148.60 million in 2030.
The market, by end user, is categorized into dermatology clinics, hospitals, cosmetic clinics, and others. The dermatology clinics segment held the largest share in mesotherapy market in 2022 and it is anticipated to register the highest CAGR during the forecast period.
The mesotherapy market majorly consists of the players, including Koru Pharma Co Ltd, Institute BCN Esthetics SL, Mesoskinline ApS, Colgate Palmolive Co, Skin Tech Pharma Group SL, HB Aesthetics Group SA, Toskani SL, Dr. Korman Laboratories Ltd, Revitacare SAS, Ostar Beauty Sci-Tech Co Ltd, Mesoestetic E-Commerce SL, Galderma SA, Derm Beauty International Sdn Bhd, and Mesotech Srl.
The mesotherapy market was valued at US$ 561.20 million in 2022.
Mesotherapy involves intradermal or subcutaneous injections of pharmaceutical preparations, enzymes, hormones, plant extracts, vitamins, and/or other ingredients such as hyaluronic acid.
Factors such as simplified and minimally invasive procedures, and wide range of applications and improvements in comfort, efficiency, and outcomes with technological advancements propel the mesotherapy market growth. However, the potential side effects and regulatory challenges hampers the growth of the market.
The List of Companies - Mesotherapy Market
- Koru Pharma Co Ltd
- Institute BCN Esthetics SL
- Mesoskinline ApS
- Colgate Palmolive Co
- Skin Tech Pharma Group SL
- HB Aesthetics Group SA
- Toskani SL
- Dr. Korman Laboratories Ltd
- Revitacare SAS
- Ostar Beauty Sci-Tech Co Ltd
- Mesoestetic E-Commerce SL
- Galderma SA
- Derm Beauty International Sdn Bhd
- Mesotech Srl
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.